Regenerx (RGN) Said Tb4 Significantly Improves Functional Recovery in MS Animal Model

September 29, 2009 12:02 PM EDT Send to a Friend
Regenerx Biopharmaceuticals (AMEX: RGN) said researchers at the Henry Ford Health System in Detroit, Michigan, demonstrated for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login